{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:01:47Z","timestamp":1743008507249,"version":"3.40.3"},"publisher-location":"Cham","reference-count":25,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031302282"},{"type":"electronic","value":"9783031302299"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-30229-9_46","type":"book-chapter","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T19:02:39Z","timestamp":1680980559000},"page":"718-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interactive Stage-Wise Optimisation of\u00a0Personalised Medicine Supply Chains"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-6272","authenticated-orcid":false,"given":"Andreea","family":"Avramescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-1295","authenticated-orcid":false,"given":"Manuel","family":"L\u00f3pez-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1236-3143","authenticated-orcid":false,"given":"Richard","family":"Allmendinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,9]]},"reference":[{"issue":"3","key":"46_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.stem.2016.08.012","volume":"19","author":"M Abou-El-Enein","year":"2016","unstructured":"Abou-El-Enein, M., Elsanhoury, A., Reinke, P.: Overcoming challenges facing advanced therapies in the EU market. Cell Stem Cell 19(3), 293\u2013297 (2016)","journal-title":"Cell Stem Cell"},{"key":"46_CR2","series-title":"Lecture Notes in Computer Science","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/978-3-030-72699-7_25","volume-title":"Applications of Evolutionary Computation","author":"A Avramescu","year":"2021","unstructured":"Avramescu, A., Allmendinger, R., L\u00f3pez-Ib\u00e1\u00f1ez, M.: A multi-objective multi-type facility location problem for the delivery of personalised medicine. In: Castillo, P.A., Jim\u00e9nez Laredo, J.L. (eds.) EvoApplications 2021. LNCS, vol. 12694, pp. 388\u2013403. Springer, Cham (2021). https:\/\/doi.org\/10.1007\/978-3-030-72699-7_25"},{"key":"46_CR3","doi-asserted-by":"crossref","unstructured":"Avramescu, A., Allmendinger, R., L\u00f3pez-Ib\u00e1\u00f1ez, M., Adriana, L.: Composite facility location problems: a case study of personalised medicine. In: 19th IEEE International Conference in Computational Intelligence in Bioinformatics and Computational Biology (2022)","DOI":"10.1109\/CIBCB55180.2022.9863037"},{"key":"46_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.compchemeng.2021.107582","volume":"157","author":"A Bernardi","year":"2022","unstructured":"Bernardi, A., Sarkis, M., Triantafyllou, N., Lakelin, M., Shah, N., Papathanasiou, M.M.: Assessment of intermediate storage and distribution nodes in personalised medicine. Comput. Chem. Eng. 157, 107582 (2022)","journal-title":"Comput. Chem. Eng."},{"key":"46_CR5","doi-asserted-by":"crossref","unstructured":"Branke, J., Farid, S.S., Shah, N.: Industry 4.0: a vision for personalized medicine supply chains? Cell Gene Therapy Insights 2(2), 263\u2013270 (2016)","DOI":"10.18609\/cgti.2016.027"},{"key":"46_CR6","unstructured":"CBER: KYMRIAH (tisagenlecleucel) (2022). https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/kymriah-tisagenlecleucel. Accessed 15 Nov 2022"},{"key":"46_CR7","unstructured":"Cornu\u00e9jols, G., Nemhauser, G., Wolsey, L.: The uncapacitated facility location problem. Technical report, Cornell University Operations Research and Industrial Engineering (1983)"},{"issue":"2","key":"46_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1109\/4235.996017","volume":"6","author":"K Deb","year":"2002","unstructured":"Deb, K., Pratap, A., Agarwal, S., Meyarivan, T.: A fast and elitist multi-objective genetic algorithm: NSGA-II. IEEE Trans. Evol. Comput. 6(2), 182\u2013197 (2002)","journal-title":"IEEE Trans. Evol. Comput."},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1145\/1143997.1144112","volume-title":"GECCO","author":"K Deb","year":"2006","unstructured":"Deb, K., Sundar, J.: Reference point based multi-objective optimization using evolutionary algorithms. In: Cattolico, M., et al. (eds.) GECCO, pp. 635\u2013642. ACM Press, New York (2006)"},{"issue":"3","key":"46_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1389201018666170224105600","volume":"18","author":"M Di Sanzo","year":"2017","unstructured":"Di Sanzo, M., et al.: Clinical applications of personalized medicine: a new paradigm and challenge. Curr. Pharm. Biotechnol. 18(3), 194\u2013203 (2017)","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"1","key":"46_CR11","doi-asserted-by":"publisher","first-page":"1600939","DOI":"10.1080\/20016689.2019.1600939","volume":"7","author":"C Eder","year":"2019","unstructured":"Eder, C., Wild, C.: Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption. J. Mark. Access Health Policy 7(1), 1600939 (2019)","journal-title":"J. Mark. Access Health Policy"},{"key":"46_CR12","unstructured":"Grand View Research: Advanced Therapy Medicinal Products Market Size, Share & Trends Analysis Report by Therapy Type (CAR-T, Gene, Cell, Stem Cell Therapy), by Region (North America, Europe, APAC, ROW), and Segment Forecasts, 2021\u20132028 (2021). https:\/\/www.grandviewresearch.com\/industry-analysis\/advanced-therapy-medicinal-products-market. Accessed 07 Apr 2021"},{"key":"46_CR13","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jcyt.2018.05.003","volume":"20","author":"RP Harrison","year":"2018","unstructured":"Harrison, R.P., Qasim, A., Medcalf, N.: Centralised versus decentralised manufacturing and the delivery of healthcare products: a United Kingdom exemplar. Cytotherapy 20, 873\u2013890 (2018)","journal-title":"Cytotherapy"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biotechadv.2017.12.013","volume":"36","author":"RP Harrison","year":"2018","unstructured":"Harrison, R.P., Ruck, S., Rafiq, Q., Medcalf, N.: Decentralised manufacturing of cell and gene therapy products: learning from other healthcare sectors. Biotechnol. Adv. 36, 345\u2013357 (2018)","journal-title":"Biotechnol. Adv."},{"key":"46_CR15","unstructured":"Institute for Health Metrics and Evaluation (IHME): IHME data (2022). http:\/\/ghdx.healthdata.org\/ihme_data. Accessed 15 Nov 2022"},{"issue":"5","key":"46_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40259-015-0140-7","volume":"29","author":"S Jaros\u0142awski","year":"2015","unstructured":"Jaros\u0142awski, S., Toumi, M.: Sipuleucel-T (Provenge\u00ae)-autopsy of an innovative paradigm change in cancer treatment: why a single-product biotech company failed to capitalize on its breakthrough invention. BioDrugs 29(5), 301\u2013307 (2015)","journal-title":"BioDrugs"},{"key":"46_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.compchemeng.2020.106913","volume":"139","author":"P Karakostas","year":"2020","unstructured":"Karakostas, P., Panoskaltsis, N., Mantalaris, A., Georgiadis, M.C.: Optimization of CAR T-cell therapies supply chains. Comput. Chem. Eng. 139, 106913 (2020)","journal-title":"Comput. Chem. Eng."},{"issue":"3","key":"46_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.18609\/cgti.2020.058","volume":"6","author":"AG Lopes","year":"2020","unstructured":"Lopes, A.G., Noel, R., Sinclair, A.: Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain. Cell Gene Therapy Insights 6(3), 487\u2013510 (2020)","journal-title":"Cell Gene Therapy Insights"},{"key":"46_CR19","doi-asserted-by":"crossref","unstructured":"Moschou, D., Papathanasiou, M.M., Lakelin, M., Shah, N.: Investment planning in personalised medicine. In: Computer Aided Chemical Engineering 30th European Symposium on Computer Aided Process Engineering, pp. 49\u201354 (2020)","DOI":"10.1016\/B978-0-12-823377-1.50009-4"},{"issue":"10\u201311","key":"46_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41417-019-0157-z","volume":"27","author":"MM Papathanasiou","year":"2020","unstructured":"Papathanasiou, M.M., Stamatis, C., Lakelin, M., Farid, S., Titchener-Hooker, N., Shah, N.: Autologous CAR T-cell therapies supply chain: challenges and opportunities? Cancer Gene Ther. 27(10\u201311), 799\u2013809 (2020)","journal-title":"Cancer Gene Ther."},{"key":"46_CR21","unstructured":"Alliance for Regenerative Medicine: Clinical Trials in Europe: Recent Trends in ATMP Development. Techncial report, Alliance for Regenerative Medicine, October 2019"},{"key":"46_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.coche.2021.100689","volume":"32","author":"M Sarkis","year":"2021","unstructured":"Sarkis, M., Bernardi, A., Shah, N., Papathanasiou, M.M.: Decision support tools for next-generation vaccines and advanced therapy medicinal products: present and future. Curr. Opin. Chem. Eng. 32, 100689 (2021)","journal-title":"Curr. Opin. Chem. Eng."},{"issue":"3","key":"46_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/pr9030457","volume":"9","author":"M Sarkis","year":"2021","unstructured":"Sarkis, M., Bernardi, A., Shah, N., Papathanasiou, M.M.: Emerging challenges and opportunities in pharmaceutical manufacturing and distribution. Processes 9(3), 457 (2021)","journal-title":"Processes"},{"key":"46_CR24","unstructured":"Syswerda, G.: Uniform crossover in genetic algorithms. In: Schaffer, J.D. (ed.) Proceedings of the Third International Conference on Genetic Algorithms, pp. 2\u20139. Morgan Kaufmann Publishers, San Mateo (1989)"},{"key":"46_CR25","doi-asserted-by":"crossref","unstructured":"Wang, X., Kong, Q., Papathanasiou, M.M., Shah, N.: Precision healthcare supply chain design through multi-objective stochastic programming. In: 13th International Symposium on Process Systems Engineering (PSE 2018) Computer Aided Chemical Engineering, pp. 2137\u20132142 (2018)","DOI":"10.1016\/B978-0-444-64241-7.50351-7"}],"container-title":["Lecture Notes in Computer Science","Applications of Evolutionary Computation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-30229-9_46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T23:11:42Z","timestamp":1681081902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-30229-9_46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031302282","9783031302299"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-30229-9_46","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"9 April 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"EvoApplications","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on the Applications of Evolutionary Computation (Part of EvoStar)","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Brno","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Czech Republic","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2023","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"12 April 2023","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"14 April 2023","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"26","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"evoapplications2023","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.evostar.org\/2023\/evoapps\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Double-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"EasyChair","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"78","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"37","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"14","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"47% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"No","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}